FDA Investigator Clifton L Randell
Clifton L Randell has conducted inspections on 5 sites in 1 countries as of 08 Nov 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
08 Nov 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Clifton L Randell:
Abdollah Koolivand,
Ana Mariaa Plapcianu,
Anita R Michael,
Bonita S Chester,
Brandon C Heitmeier,
Camerson E Moore,
Christopher D Leach,
Constance Y Fears,
Demario L Walls,
Desiree D Clark,
Diane P Goyette,
Frank Wackes,
Jamie L Port,
Jared P Stevens,
Jessica L Pressley,
Julianne C Mccullough,
June P Page,
Kemejumaka N Opara,
Kimberly Lewandowski Walker,
Kristina J Donohue,
Larry K Hampton,
Lisa T Michel,
Margaret M Annes,
Mary Jeanet Mcgarry,
Melanie M Walker,
Melissa J Holz,
Michelle J Glembin,
Narong Chamkasem, PhD,
Nicholas Z Lu,
Nicole A Lloyd,
Noreen Muñiz,
Philip F Istafanos, DMV, MS,
Postelle Birch Smith,
Rachael L Cook,
Richard Jay Tucker, RS,
Russell J Glapion,
Sara M Onyango,
Sara M Richardson,
Saundrea A Munroe,
Sayeeda Hdabe,
Seneca D Toms,
Sharna D Pratt,
Song Y Lavalais,
Sonya M Edmonds,
Stephen D Brown,
Thomas E Friel,
Vincent Thomas
Clifton L Randell's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2018 | FDA 483 | Becton Dickinson Medical Systems - Form 483, 2018-08-01 |
February, 2023 | FDA 483 Response | Nephron Sterile Compounding Center, LLC - Form 483R, 2023-03-06 |
February, 2023 | FDA 483 | Nephron Sterile Compounding Center, LLC - Form 483, 2023-02-10 |
August, 2018 | FDA 483 Response | Becton Dickinson Medical Systems - Form 483R, 2018-08-21 |
February, 2020 | FDA 483 | Strive Pharmacy Texas LLC dba Strive Pharmacy - Form 483, 2020-02-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more